Skip to main content
. 2023 Aug 23;25(9):817–827. doi: 10.1111/jch.14707

FIGURE 1.

FIGURE 1

Flowchart of the study design. This is a randomized, double‐blind, active‐controlled, multicenter phase 3 trial to evaluate the safety and efficacy of telmisartan/amlodipine/chlorthalidone triple combination treatment in patients with primary hypertension inappropriately controlled on telmisartan/amlodipine dual combination treatment. TEL/AML/CHTD, telmisartan/amlodipine/chlorthalidone; TEL/AML, telmisartan/amlodipine.